|
Re: MACE Events - Statistically Confusing
|
3
|
Resverlogix Corp.
|
Mar 01, 2019 08:59AM
|
|
Re: MACE Events - Statistically Confusing
|
4
|
Resverlogix Corp.
|
Mar 01, 2019 12:37PM
|
|
Re: MACE Events - Statistically Confusing
|
3
|
Resverlogix Corp.
|
Mar 01, 2019 02:33PM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
1
|
Resverlogix Corp.
|
Nov 29, 2018 10:38AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
3
|
Resverlogix Corp.
|
Nov 29, 2018 11:01AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
2
|
Resverlogix Corp.
|
Nov 29, 2018 11:49AM
|
|
Re: MACE question
|
1
|
Resverlogix Corp.
|
Jun 20, 2019 10:32PM
|
|
Re: madrid
|
2
|
Resverlogix Corp.
|
May 30, 2017 06:42AM
|
|
Re: Madrid
|
2
|
Resverlogix Corp.
|
Jun 06, 2017 10:06PM
|
|
Re: Madrid Conferance
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 22, 2016 11:06AM
|
|
Re: Making a "big deal" out of November 15
|
5
|
Resverlogix Corp.
|
Nov 14, 2016 10:34AM
|
|
Re: Managed to catch up with Mark Day last night...
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 01:04PM
|
|
Re: MANAGEMENT: We deserve an update on Zenith
|
5
|
Zenith Epigenetics
|
Mar 31, 2016 09:08PM
|
|
Re: Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
|
4
|
Resverlogix Corp.
|
May 17, 2017 12:29PM
|
|
Re: Managing Diabetes & CVD: Is epigenetics a new way forward?
|
3
|
Resverlogix Corp.
|
Jun 23, 2017 10:51AM
|
|
Re: Managing Diabetes & CVD: Is epigenetics a new way forward?
|
3
|
Resverlogix Corp.
|
Jun 23, 2017 01:39PM
|
|
Re: Managing the message
|
5
|
Resverlogix Corp.
|
Jun 08, 2016 09:25AM
|
|
Re: Many hands make light work....
|
3
|
Resverlogix Corp.
|
Aug 22, 2018 06:58AM
|
|
Re: Many hands make light work....
|
4
|
Resverlogix Corp.
|
Aug 22, 2018 07:25AM
|
|
Re: March Madness
|
2
|
Resverlogix Corp.
|
Mar 20, 2017 01:01PM
|
